Boston Scientific Corporation vs Conagra Brands Inc — how do they compare? Boston Scientific Corporation trades at $51 (market cap $71.46B), while Conagra Brands Inc trades at $14.93 (market cap $7.07B). The key difference: Boston Scientific Corporation is far larger — about 10.1× Conagra Brands Inc's market cap, and Conagra Brands Inc pays a 8.29% dividend while Boston Scientific Corporation pays none. Which is the better fit depends on your goals.
| BSX | CAG | |
|---|---|---|
Market Cap | $71.46B | $7.07B |
Sector | Health | Consumer Staples |
52-Week High | $108.14 | $20.02 |
52-Week Low | $42.63 | $12.58 |
Enterprise Value | $83.55B | $14.12B |
Dividend Yield | — | 8.29% |
Trailing returns across standard periods
Latest headlines on both assets
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →Conagra Brands is a packaged food company that operates predominantly in the United States (over 90% of revenue and profits). It has a significant presence in the freezer aisle, with brands such as Marie Callender's, Healthy Choice, Banquet, and Birds Eye. Other popular brands include Duncan Hines, Hunt's, Slim Jim, Vlasic, Orville Redenbacher's, Reddi-wip, Wish-Bone, and Chef Boyardee. While the majority of revenue is sold into the U.S. retail channel, 9% of fiscal 2022 sales were to the food-service channel, down from 11% in fiscal 2019 due to the pandemic.
Read more on CAG →